Agilon Health, Inc. (NYSE:AGL - Get Free Report) was the target of unusually large options trading on Tuesday. Stock traders bought 3,810 call options on the company. This represents an increase of 187% compared to the typical volume of 1,328 call options.
Analyst Upgrades and Downgrades
A number of research firms have recently commented on AGL. Needham & Company LLC restated a "hold" rating on shares of Agilon Health in a report on Friday, March 21st. TD Cowen increased their price target on Agilon Health from $3.50 to $6.00 and gave the company a "hold" rating in a report on Tuesday, April 15th. Cowen reiterated a "hold" rating on shares of Agilon Health in a report on Tuesday, April 15th. Wells Fargo & Company lowered their price target on Agilon Health from $6.00 to $5.00 and set an "overweight" rating for the company in a report on Tuesday, May 13th. Finally, Barclays increased their price target on Agilon Health from $2.00 to $3.00 and gave the company an "underweight" rating in a report on Thursday, May 8th. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $4.79.
Check Out Our Latest Analysis on AGL
Hedge Funds Weigh In On Agilon Health
A number of large investors have recently bought and sold shares of the business. Empowered Funds LLC acquired a new stake in shares of Agilon Health in the fourth quarter valued at approximately $97,000. Rhumbline Advisers increased its stake in shares of Agilon Health by 6.2% in the fourth quarter. Rhumbline Advisers now owns 419,587 shares of the company's stock valued at $797,000 after purchasing an additional 24,420 shares during the period. Alberta Investment Management Corp acquired a new stake in shares of Agilon Health in the fourth quarter valued at approximately $1,564,000. Ieq Capital LLC acquired a new stake in shares of Agilon Health in the fourth quarter valued at approximately $26,000. Finally, Handelsbanken Fonder AB increased its stake in shares of Agilon Health by 47.9% in the fourth quarter. Handelsbanken Fonder AB now owns 75,000 shares of the company's stock valued at $142,000 after purchasing an additional 24,300 shares during the period.
Agilon Health Stock Performance
Shares of AGL stock traded down $0.07 during trading hours on Friday, hitting $2.12. 3,120,954 shares of the company were exchanged, compared to its average volume of 4,982,258. Agilon Health has a one year low of $1.50 and a one year high of $7.73. The business's 50-day simple moving average is $3.03 and its two-hundred day simple moving average is $3.20. The stock has a market capitalization of $875.50 million, a price-to-earnings ratio of -3.58 and a beta of 0.14.
Agilon Health (NYSE:AGL - Get Free Report) last issued its quarterly earnings results on Tuesday, May 6th. The company reported $0.03 EPS for the quarter, topping the consensus estimate of ($0.01) by $0.04. Agilon Health had a negative net margin of 4.04% and a negative return on equity of 45.47%. The business had revenue of $1.53 billion for the quarter, compared to analysts' expectations of $1.50 billion. During the same quarter last year, the company posted ($0.02) earnings per share. The company's quarterly revenue was down 4.5% compared to the same quarter last year. As a group, analysts anticipate that Agilon Health will post -0.59 EPS for the current fiscal year.
Agilon Health Company Profile
(
Get Free Report)
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Further Reading
Before you consider Agilon Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilon Health wasn't on the list.
While Agilon Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.